Archive for July, 2019

IDSA’s Insincere Request For Guidelines Feedback

https://www.lymedisease.org/idsa-insincere-request/

19 JUL 2019
By Dorothy Kupcha Leland  Touched by Lyme

Last month, the IDSA released a long-awaited draft of its latest Lyme treatment guidelines. The accompanying announcement stated: “We are looking for feedback from not only physicians and healthcare professionals, but also individuals affected by Lyme disease, such as patients, care givers, patient organization members, advocates, and researchers.”

Maybe you thought you’d print off the 100-page report and curl up on the couch to read it? Ain’t gonna happen.
How about downloading a PDF and reading it on your Kindle? Heck no.

Why not, you ask? Because the IDSA has purposely made it impossible for anybody to make a copy of either the guidelines or the 200-page list of accompanying resources.

The only way to read any of it is to go to the IDSA website and view it in real time on your screen.

Makes you wonder how serious that request for public feedback actually is, doesn’t it? This cumbersome process makes it difficult for anybody to read such long documents—whether you are a patient, a busy doctor, or a journalist interested in the story.

Wait. We’re not done yet. After you’ve slogged through all that just to read the darn thing, there’s another burdensome procedure for making comments.

Here’s how the IDSA website explains it:

In this form, you are given 20 opportunities to enter your comments on the guideline. Please note that you will need to complete your review in one sitting as your work in progress cannot be saved. Once you hit the “Save and Next” button at the end, your responses will be recorded and saved. If at the end you have additional comments, please click “Enter Additional Comments” and complete the survey again.

For each comment, you must select which section of the guideline your comment relates to:

·       General comments on entire draft

·       Introduction & methods

·       Tick bites prevention and prophylaxis of Lyme disease

·       Early localized Lyme disease (erythema migrans)

·       Neurologic Lyme disease

·       Lyme carditis

·       Lyme arthritis

·       Prolonged symptoms following treatment of Lyme disease

·       Cutaneous manifestations of Eurasian Lyme disease

·       Lyme disease coinfections

·       Supplement Materials

For each comment, you must be specific (section, page number, line and/or table number, comment).

Any questions marked with an asterisk (*) require an answer in order to progress through the comment form.

You must click “Save and Next” at the bottom of each page or your responses will not be saved.

Complicated enough for you?

LymeDisease.org is currently going over the draft guidelines with a fine-tooth comb and will have comments ready soon. Stay tuned.

Aside from the content of the document itself—which, spoiler alert! is plenty disturbing—the process by which the IDSA arrived at this draft is highly problematic.

Why the guidelines matter

For those who may be new to this party, some background:

The 2006 IDSA Lyme guidelines have long been a point of contention. They rigidly define what is “allowed” to be diagnosed as Lyme disease and limit permissible treatment to a short course of antibiotics. Thus, they deny treatment to the unlucky many who don’t fall within those narrow parameters.

Furthermore, insurance companies often use the guidelines to deny payment for Lyme treatment, and medical boards use them to revoke licenses of physicians who don’t follow them. Currently, the guidelines are also the centerpiece of a federal lawsuit. It charges that the document’s authors and eight insurance companies conspired to deny medical care to Lyme disease patients.

In 2016, the IDSA announced that it would re-evaluate and update the Lyme guidelines. At the time, the group also announced with much fanfare that they had named a “patient representative” on the guidelines panel. When our organization spoke to her, the woman in question admitted that she had no experience with Lyme disease whatsoever!

After the Lyme community protested loudly, the IDSA changed her designation from “patient representative” to “consumer representative.” They also said they would add three “patients” to the panel as well. But “to protect their privacy,” the IDSA refused to name the people who were supposedly there to “represent” us.

So basically, three people we’ve never heard of—and never will hear of—supposedly spoke on behalf of the Lyme community throughout the guidelines process. Are you feeling “represented” yet?

Click here for the draft guidelines.

______________________________

For more:  https://madisonarealymesupportgroup.com/2019/07/09/idsa-lyme-disease-treatment-management-business-as-usual-leaves-those-with-persisting-symptoms-to-suffer-die/

https://madisonarealymesupportgroup.com/2019/06/27/idsa-aan-acr-2109-draft-lyme-guidelines-public-comments-allowed-until-aug-10-2019/

https://madisonarealymesupportgroup.com/2017/06/29/british-lord-says-cdcidsa-lyme-guidelines-not-fit-for-purpose/

https://madisonarealymesupportgroup.com/2017/08/19/dr-liegner-guidelines-used-by-managed-care-causing-lyme-deaths/

 

Did Pentagon Turn Ticks into Bioweapons That Spread Lyme Disease? N.J. Congressman Wants Answers

Did Pentagon turn ticks into bioweapons that spread Lyme Disease? N.J. congressman wants answers.

Rep. Chris Smith speaks in Middletown at a 9/11 memorial ceremony. ( Tom Haydon | NJ Advance Media for NJ.com)

Tom Haydon | NJ Advance Media

Rep. Chris Smith speaks in Middletown at a 9/11 memorial ceremony. ( Tom Haydon | NJ Advance Media for NJ.com)

WASHINGTON

It sounds like the plot for a science fiction movie: A government agency decides to use ticks and other insects to spread disease and kill its enemies, only the ticks got out and infected the country’s residents itself.

New Jersey Rep. Chris Smith says that may not be too far-fetched.

He’s won approval from the House to have the Defense Department’s inspector general investigate whether the Pentagon actually looked at using ticks stuffed with pathogens as bioweapons during the height of the Cold War beginning in the 1950s.

He said several books and articles pinned the blame on the Pentagon, and perhaps some of the ticks and insects got out and helped to spread illnesses, most notably Lyme disease.

“If this isn’t true, let’s put it to rest,” said Smith, R-4th Dist. “For the sake of public health we should demand these answers.”

The provision is part of the National Defense Authorization Act, which sets defense policy for the 12 months beginning Oct. 1. That’s the same bill that includes Pentagon projects at Joint Base McGuire-Dix-Lakehurst and the Picatinny Arsenal, as well as prevents President Donald Trump from launching an attack on Iran without first receiving congressional approval.

House Democrats allowed Smith to bring up an amendment to begin the study, and then joined with Republicans in unanimously adding it to the legislation.

“With Lyme disease and other tick-borne diseases exploding in the United States — with an estimated 300,000 to 437,000 new cases diagnosed each year and 10-20 percent of all patients suffering from chronic Lyme disease — Americans have a right to know whether any of this is true,” Smith said. “And have these experiments caused Lyme disease and other tick-borne disease to mutate and to spread?”

Since a similar provision is not in the Senate version of the bill, it will be up to congressional negotiators to make sure it makes the final defense legislation. Smith said he’s talking to Senate leaders to gain their ascent.

The Lyme Disease Association is pushing senators to agree to the study.

“We know that the government was doing other kinds of experiments during that time,” said Pat Smith, president of the Jackson, N.J.-based group. “Absolutely it needs to be looked at. The public needs to know if this has occurred.”

And if it turns to be true?

“Maybe there is something in the research that would lead to helping patients get better or constrain the spread of ticks across the country,” Smith said.

Newby Responds to Washington Post’s Slam About Bitten

https://www.lymedisease.org/newby-responds-wapo/

Newby responds to Washington Post’s slam about BITTEN

 

 

 

Human Seroprevalence of Tick-Borne Anaplasma, Lyme, and Rickettsia Species in Northern California

https://www.ncbi.nlm.nih.gov/pubmed/31295054/

2019 Jul 11. doi: 10.1089/vbz.2019.2489. [Epub ahead of print]

Human Seroprevalence of Tick-Borne Anaplasma phagocytophilum, Borrelia burgdorferi, and Rickettsia Species in Northern California.

Abstract

There is a paucity of data on human exposure to tick-borne pathogens in the western United States. This study reports prevalence of antibodies against three clinically important tick-borne pathogens (Borrelia burgdorferi, Anaplasma phagocytophilum, and Rickettsia spp.) among 249 people in five counties in northern California. Individuals from Humboldt County were recruited and answered a questionnaire to assess risk of exposure to tick-borne pathogens. Samples from other counties were obtained from a blood bank and were anonymized. Seventeen (6.8%) samples were seropositive for antibodies against at least one pathogen: five for A. phagocytophilum, eight for B. burgdorferi, and four for Rickettsia spp. Women and people aged 26-35 had higher seroprevalence compared to other demographic groups. Santa Cruz County had no seropositive individuals, northern Central Valley counties had three seropositive individuals (all against A. phagocytophilum), and Humboldt County had 14 (all three pathogens), a significant, four-fold elevated risk of exposure. The Humboldt County questionnaire revealed that a bird feeder in the yard was statistically associated with exposure to ticks, and lifetime number of tick bites was associated with increasing age, time watching wildlife, and time hiking. Three-quarters of respondents were concerned about tick-associated disease, 81.0% reported experiencing tick bites, and 39.0% of those bitten reported a tick-borne disease symptom, including skin lesions (76.4%), muscle aches (49.1%), joint pain (25.5%), or fever (23.6%).

Despite high levels of concern, many individuals who had been bitten by a tick were not tested for a tick-borne pathogen, including those with consistent symptoms.

We highlight the need for further research and dissemination of information to residents and physicians in Northern California regarding tick-associated disease, so that appropriate medical attention can be rapidly sought and administered.

________________

**Comment**

Again, the numbers are going to be much higher as they used the abysmal serology testing which tests for antibodies – not the organisms.

More on California:  https://madisonarealymesupportgroup.com/2018/05/24/lyme-in-california-what-you-need-to-know/

https://madisonarealymesupportgroup.com/2018/05/19/infected-ticks-in-california-its-complicated/

https://madisonarealymesupportgroup.com/2017/08/07/california-lyme-cases-get-no-respect/

https://madisonarealymesupportgroup.com/2018/06/23/say-what-california-fifth-in-nation-for-lyme-insurance-claims/

https://madisonarealymesupportgroup.com/2018/02/02/miyamotoi-in-ixodes-pacificus-in-california/

https://madisonarealymesupportgroup.com/2018/02/15/b-miyamotoi-in-ca-ticks-for-a-long-time/

https://madisonarealymesupportgroup.com/2018/02/14/borrelia-miyamotoi-in-ca-serodiagnosis-is-complicated-by-multiple-endemic-borrelia-species/

https://madisonarealymesupportgroup.com/2017/10/09/bb-in-california-chipmunk-and-squirrels/

https://madisonarealymesupportgroup.com/2019/05/26/educating-california-about-lyme-disease/

Folate Pathway Modulation in Brown Dog Tick in Response to Infection

https://www.ncbi.nlm.nih.gov/pubmed/31231926

2019 Jun 24. doi: 10.1111/tbed.13231. [Epub ahead of print]

Folate pathway modulation in Rhipicephalus ticks in response to infection.

Abstract

Folate pathways components were demonstrated to be present in RNA-sequencing data obtained from uninfected and pathogen-infected Rhipicephalus ticks. Here, PCR and qPCR allowed the identification of folate-related genes in Rhipicephalus spp. ticks and in the tick cell line IDE8. Genes coding for GTP cyclohydrolase I (gch-I), thymidylate synthase (ts) and 6-pyrovoyltetrahydropterin (ptps) were identified. Differential gene expression was evaluated by qPCR between uninfected and infected samples of four biological systems, showing significant upregulation and largest fold-change for the gch-I gene in the majority of the biological systems, supporting the selection for functional analysis by RNAi silencing. Efficient knockdown of the gch-I gene in uninfected and Ehrlichia canis-infected IDE8 cells showed no detectable impact on the capacity of the bacteria to invade or replicate in the tick cells. Overall, this work demonstrated an increase in the expression of some folate-related genes, though not always statistically significantly, in the presence of infection, suggesting gene expression modulation of these pathways, either as a tick response to an invader or manipulation of the tick cell machinery by the pathogens to their advantage. This discovery points to folate pathways as interesting targets for further studies.